Brief: Extrawell Pharmaceutical Holdings Posts H1 Revenue Of HKD 30.8 Mln
29/11/2024 11:43
Nov 29 (Reuters) - Extrawell Pharmaceutical Holdings H1 net income attributable HKD 100.9 million. * H1 revenue HKD 30.8 million
Recent news on Extrawell Pharmaceutical Holdings
See all newsBrief: Extrawell Pharmaceutical Abandons Negotiations For Possible Sale Of Convertible Bonds
Brief: Extrawell Pharmaceutical Proposes Share Consolidation Of 20 Shares Into 1 Share Of HK$0.20 Par Value
Brief: Extrawell Pharmaceutical Says Mr. Wu Xiangyun Appointed As Executive Director
Brief: Extrawell Pharmaceutical Expects FY Loss Of At Least HK$950 Million
Brief: Extrawell Pharmaceutical's Unit To Buy Back 10.06% Of Its Stake For RMB4.4 Million